B. Dardik

发表

Fibrinopeptide B and Aggregation of Fibrinogen

J. Shainoff, B. Dardik, 1979, Thrombosis and Haemostasis.

Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity

P. McNamara, J. Gromada, S. Commerford, 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly.

B. Dardik, C. Schwartzkopf, R. Chatelain, 2000, Journal of lipid research.

Increased DNA Replication in the Arterial Adventitia After Aortic Ligation

B. Dardik, R. Chatelain, 1988, Hypertension.

Crosslinking of Monomeric Fibrin by Factor XIIIa

J. Shainoff, B. Dardik, 1979, Thrombosis and Haemostasis.

Role of fibrinogen in fibrin transport: chromatographic studies.

J. Shainoff, B. Dardik, 1980, Thrombosis research.

Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.

J. Shainoff, B. Dardik, 1990, The Journal of laboratory and clinical medicine.

FIBRINOPEPTIDE B IN FIBRIN ASSEMBLY AND METABOLISM: PHYSIOLOGIC SIGNIFICANCE IN DELAYED RELEASE OF THE PEPTIDE *

J. Shainoff, B. Dardik, 1983, Annals of the New York Academy of Sciences.

Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.

J. Shainoff, B. Dardik, 1985, Blood.

Elevated arterial cyclic AMP levels during the development of spontaneous hypertension in rats.

B. Dardik, R. D. Robson, R. Chatelain, 1985, European journal of pharmacology.

Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer

J. Shainoff, B. Dardik, 1985 .

Cascade immunoelectrophoresis: combined electrophoretic and solid-phase processing of immunoreactive protein by zonal immobilization.

J. Shainoff, B. Dardik, 1981, Journal of immunological methods.

Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.

S. De Lombaert, R. Lappe, B. Dardik, 1998, The Journal of pharmacology and experimental therapeutics.

Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.

A. Jeng, P. Kukkola, J. Stanton, 2005, Journal of medicinal chemistry.

Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys.

J. Gromada, Hong Chen, B. Dardik, 2010, Endocrinology.

Acute arterial fibrinoid deposition and ischaemic parenchymal damage of the kidney. Pathogenic factors in the development of malignant hypertension

J. Shainoff, B. Dardik, R. Chatelain, 1983, The Journal of pathology.

Impaired arterial collagen and elastin metabolism in experimental malignant hypertension.

P. Dibello, C. Ferrario, L. Ehrhart, 1981, The Journal of laboratory and clinical medicine.

Malignant hypertension, fibrinoid deposition, and fibrinogen electrophoresis.

J. Shainoff, P. Dibello, C. Ferrario, 1989, Cleveland Clinic journal of medicine.